JP4993391B2 - Slimming application agent for slimming method - Google Patents
Slimming application agent for slimming method Download PDFInfo
- Publication number
- JP4993391B2 JP4993391B2 JP2009143803A JP2009143803A JP4993391B2 JP 4993391 B2 JP4993391 B2 JP 4993391B2 JP 2009143803 A JP2009143803 A JP 2009143803A JP 2009143803 A JP2009143803 A JP 2009143803A JP 4993391 B2 JP4993391 B2 JP 4993391B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- slimming
- acid
- coating composition
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title description 10
- 239000000284 extract Substances 0.000 claims description 57
- 239000008199 coating composition Substances 0.000 claims description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- -1 grapefruit extract Chemical compound 0.000 claims description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 10
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 235000005158 Thymus praecox ssp. arcticus Nutrition 0.000 claims description 9
- 235000004054 Thymus serpyllum Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 8
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 8
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 8
- 235000013922 glutamic acid Nutrition 0.000 claims description 8
- 239000004220 glutamic acid Substances 0.000 claims description 8
- 229940010454 licorice Drugs 0.000 claims description 8
- 210000001165 lymph node Anatomy 0.000 claims description 8
- 239000004475 Arginine Substances 0.000 claims description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 7
- 241000199919 Phaeophyceae Species 0.000 claims description 7
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 7
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 7
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 7
- 239000004473 Threonine Substances 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- 229960003237 betaine Drugs 0.000 claims description 7
- KDULJHFMZBRAHO-UHFFFAOYSA-N cioteronel Chemical compound C1C(=O)CC2C(CCCCC(CC)OC)CCC21 KDULJHFMZBRAHO-UHFFFAOYSA-N 0.000 claims description 7
- 229930003935 flavonoid Natural products 0.000 claims description 7
- 235000017173 flavonoids Nutrition 0.000 claims description 7
- 150000002215 flavonoids Chemical class 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 6
- 240000004507 Abelmoschus esculentus Species 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 241000195628 Chlorophyta Species 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 claims description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- 229930195725 Mannitol Natural products 0.000 claims description 6
- 235000019483 Peanut oil Nutrition 0.000 claims description 6
- 241000206572 Rhodophyta Species 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 235000004279 alanine Nutrition 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 6
- 229940114124 ferulic acid Drugs 0.000 claims description 6
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 6
- 235000001785 ferulic acid Nutrition 0.000 claims description 6
- 229930195712 glutamate Natural products 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229940065115 grapefruit extract Drugs 0.000 claims description 6
- 239000000594 mannitol Substances 0.000 claims description 6
- 235000010355 mannitol Nutrition 0.000 claims description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 6
- 239000000312 peanut oil Substances 0.000 claims description 6
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 claims description 6
- 229940032094 squalane Drugs 0.000 claims description 6
- 239000011732 tocopherol Substances 0.000 claims description 6
- 229960001295 tocopherol Drugs 0.000 claims description 6
- 229930003799 tocopherol Natural products 0.000 claims description 6
- 235000010384 tocopherol Nutrition 0.000 claims description 6
- 229940042585 tocopherol acetate Drugs 0.000 claims description 6
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 5
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims description 5
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 5
- 229960005150 glycerol Drugs 0.000 claims description 5
- 239000011769 retinyl palmitate Substances 0.000 claims description 5
- 229940108325 retinyl palmitate Drugs 0.000 claims description 5
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000010356 sorbitol Nutrition 0.000 claims description 5
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 4
- 241000219780 Pueraria Species 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- 241001501711 Walteria Species 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 239000000176 sodium gluconate Substances 0.000 claims description 4
- 235000012207 sodium gluconate Nutrition 0.000 claims description 4
- 229940005574 sodium gluconate Drugs 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 claims description 3
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims description 3
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 3
- FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 claims description 3
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 3
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 claims description 3
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 3
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 3
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 claims description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 claims description 3
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 3
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 3
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 3
- 229940123973 Oxygen scavenger Drugs 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 241000242583 Scyphozoa Species 0.000 claims description 3
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 3
- LZDNBBYBDGBADK-KBPBESRZSA-N Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-KBPBESRZSA-N 0.000 claims description 3
- 235000009697 arginine Nutrition 0.000 claims description 3
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 claims description 3
- 229930183167 cerebroside Natural products 0.000 claims description 3
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 claims description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 3
- 229940043370 chrysin Drugs 0.000 claims description 3
- 235000015838 chrysin Nutrition 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 229940008099 dimethicone Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- 229960004585 etidronic acid Drugs 0.000 claims description 3
- 235000008524 evening primrose extract Nutrition 0.000 claims description 3
- 229940089020 evening primrose oil Drugs 0.000 claims description 3
- 239000010475 evening primrose oil Substances 0.000 claims description 3
- 229940108690 glucosyl hesperidin Drugs 0.000 claims description 3
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims description 3
- 229940076640 hesperidin methylchalcone Drugs 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 229940057905 laureth-3 Drugs 0.000 claims description 3
- 235000020725 licorice root extract Nutrition 0.000 claims description 3
- 229940051810 licorice root extract Drugs 0.000 claims description 3
- 229940049918 linoleate Drugs 0.000 claims description 3
- 235000018977 lysine Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000010466 nut oil Substances 0.000 claims description 3
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229940068977 polysorbate 20 Drugs 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 229940068968 polysorbate 80 Drugs 0.000 claims description 3
- 229940093932 potassium hydroxide Drugs 0.000 claims description 3
- 235000013930 proline Nutrition 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 229950004959 sorbitan oleate Drugs 0.000 claims description 3
- 229940100459 steareth-20 Drugs 0.000 claims description 3
- 235000008521 threonine Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 2
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 240000006001 Thymus serpyllum Species 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 1
- 235000011083 sodium citrates Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 description 19
- 150000001413 amino acids Chemical class 0.000 description 14
- 210000002751 lymph Anatomy 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 13
- 239000004480 active ingredient Substances 0.000 description 9
- 241001474374 Blennius Species 0.000 description 7
- 241000754257 Thymus praecox Species 0.000 description 6
- 239000004367 Lipase Substances 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 229940015975 1,2-hexanediol Drugs 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 235000019626 lipase activity Nutrition 0.000 description 3
- 210000001365 lymphatic vessel Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- BVYZDBLMCKSKAT-UHFFFAOYSA-N 2,2,3,3-tetrahexyldecanoic acid Chemical compound CCCCCCCC(CCCCCC)(CCCCCC)C(CCCCCC)(CCCCCC)C(O)=O BVYZDBLMCKSKAT-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 241001629703 Pueraria candollei var. mirifica Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 230000002366 lipolytic effect Effects 0.000 description 2
- 229960001855 mannitol Drugs 0.000 description 2
- 210000004088 microvessel Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000510609 Ferula Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 244000238515 Thymus pulegioides Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 150000001602 bicycloalkyls Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- IIRFCWANHMSDCG-UHFFFAOYSA-N cyclooctanone Chemical compound O=C1CCCCCCC1 IIRFCWANHMSDCG-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000009408 flooring Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
この発明は、特定の塗布組成物及び生育光線の照射によりリンパ内の脂肪分等を分解するとともに、リンパを活性化させてリンパ内の分解物を排出させるようにした痩身方法に関するものである。 The present invention relates to a specific coating composition and a slimming method that decomposes fat and the like in lymph by irradiation with growth light, and activates the lymph to discharge the degradation product in lymph.
体内に張り巡らされたリンパ系の一つの重要な機能として組織からリンパ管内に吸収した脂質を骨格筋等の収縮作用により流動させ、リンパ節を通して循環系に運搬する機能が挙げられるが、年齢を重ねるに従って骨格筋等の収縮作用が弱まり、その結果リンパ管内に脂質が蓄積され、肥満の原因となっている。 One important function of the lymphatic system that stretches around the body is the function of causing the lipid absorbed into the lymphatic vessels from the tissue to flow by the contracting action of skeletal muscles and transporting it through the lymph nodes to the circulatory system. As they overlap, the contractile action of skeletal muscle and the like weakens, and as a result, lipid accumulates in the lymphatic vessels, causing obesity.
このようにリンパ管内に蓄積された脂質を取り去る局所的痩身法として、従来局所マッサージ法、鍼灸法、外科的手法などが実施されているが、痩身用塗布組成物についても種々の提案がなされている。 As a local slimming method for removing the lipid accumulated in the lymphatic vessels in this way, a local massage method, acupuncture method, a surgical technique, etc. have been conventionally carried out, but various proposals have been made for a slimming coating composition. Yes.
このうち脂肪分解酵素(リパーゼ)を活性化させるものとして、cAMPを有効成分とするもの(特開平11-116486号)、ツツラフジ科植物の抽出物を有効成分とするもの(特開平11-269079号)、カフェイン、海藻エキスを有効成分とするもの(特開平8-104618号)、W02002/005755)、植物抽出物を有効成分とするもの(特公平3-68004号、特開2000-63227)、生薬を有効成分とするもの(特開平7-228522号)等が開示されている。 Among them, those that activate lipolytic enzyme (lipase) include cAMP as an active ingredient (Japanese Patent Laid-Open No. 11-116486), and those that use an extract of a scorpionaceae plant (Japanese Patent Laid-Open No. 11-269079) ), Those containing caffeine and seaweed extract as active ingredients (Japanese Patent Laid-Open No. 8-104618), W02002 / 005755), those containing plant extracts as active ingredients (Japanese Patent Publication No. 3-68004, Japanese Patent Laid-Open No. 2000-63227) In addition, those containing a crude drug as an active ingredient (Japanese Patent Laid-Open No. 7-228522) are disclosed.
更に、本願発明者は先に、エトキシヘプチルビシクロオクタノン、ワイルドタイムエキス、甘草フラボノイド等を含む局所痩身用マッサージ製剤(特開2007-159689)を提案した。 Furthermore, the present inventor has previously proposed a massage preparation for local slimming (JP 2007-159689) containing ethoxyheptylbicyclooctanone, wild thyme extract, licorice flavonoids and the like.
本願発明者は、自ら開発した塗布組成物A、塗布組成物Bを塗布した後、39℃近傍の温度で約1時間生育光線を照射することにより、単にリパーゼ活性化成分、リンパ活性化成分を含む塗布組成物を塗布するだけでは得られない痩身効果が得られることを見出した。 The present inventor simply applied the coating composition A and the coating composition B developed by himself, and then irradiated the growth light at a temperature of about 39 ° C. for about 1 hour, so that the lipase activating component and the lymph activating component were simply added. It has been found that a slimming effect that cannot be obtained simply by applying a coating composition containing it is obtained.
そこで、この発明はエトキシヘプチルビシクロオクタノンとワイルドタイムエキスと甘草フラボノイドの有効成分を含む塗布組成物Aとテトラヘキシルデカン酸アスコルビル、ワルテリアインディカ葉エキスを含む塗布組成物Bを塗布した後、55℃〜45℃、好ましくは50℃近傍で1時間程度保持しながら生育光線を照射する痩身方法を提案するものである。 Therefore, the present invention was applied at 55 ° C. after applying coating composition A containing ethoxyheptylbicyclooctanone, wild thyme extract and active ingredients of licorice flavonoid and coating composition B containing tetrahexyldecanoate ascorbyl and walteria indica leaf extract. The present invention proposes a slimming method in which a growing ray is irradiated while maintaining at about 45 ° C., preferably around 50 ° C. for about 1 hour.
この発明に使用される塗布組成物Aは有効成分としてエトキシヘプチルビシクロオクタノンとワイルドタイムエキスと甘草フラボノイドが含まれている。 The coating composition A used in the present invention contains ethoxyheptylbicyclooctanone, wild thyme extract and licorice flavonoid as active ingredients.
このうち、ワイルドタイムエキスと甘草フラボノイは、その相互作用により脂質を分解し、分解物をリンパに排出し、またエトキシヘプチルビシクロオクタノンはリンパの働きを活性化してこれらの分解物をリンパ液により運び去るものと推定される。 Of these, wild time extract and licorice flavonoi break down lipids by their interaction and excrete the degradation products to the lymph, and ethoxyheptylbicyclooctanone activates the action of lymph and carries these degradation products by lymph. Presumed to leave.
なお、この発明に使用される塗布組成物Aには、痩身効果乃至化粧料としての効果を発揮させるための基礎成分が配合される。 The coating composition A used in the present invention is blended with basic components for exerting a slimming effect or a cosmetic effect.
これらの基礎成分をを例示すると、水(溶剤)、BG、ホホバ油、スクワラン、グリセリン(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、プエラリアミルフィカ根エキス、ヘスペリジンメチルカルコン、ジペプチド−2、パルミトイルペンタペプチド−3、パルミトイルテトラペプチド−3、パルミトイルオリゴペプチド、クリシン、N−ヒドロキシコハク酸イミド、アセチルジペプチド−1セチル、アセチルヘキサペプチド−3、グレープフルーツエキス、ヒアルロン酸Na、テトラヘキシルデカン酸アスコビル、セレブロシド、ワルテリアインディカ葉エキス、ベタイン、PCA-Na、ソルビトール、セリン、グリシン、グルタミン酸、アラニン、リシン、アルギニン、トレオニン、プロリン、月見草油、シロキクラゲ多糖体、フェルラ酸、グルコン酸Na、加水分解オクラ種子エキス、酢酸トコフェロール、パルミチン酸レチノール、リノール酸トコフェロール、マカデミアナッツ油、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル)、リンゴ酸ジイソステアリル、シクロペンタシロキサン、ジメチコン、1,2−ヘキサンジオール、マンニトール、デキストリン、ジメチコノール、クエン酸、クエン酸Na、カプリリルグリコール、オレイン酸ソルビタン、ポリソルベート80、ステアレス−20、ラウレス−3、ヒドロキシエチルセルロース、ポリソルベート60、ポリソルベート20、カルボマ−、ラウリン酸ポリグリセリル−10、ピーナッツ油、ペンチレングリコール、エチドロン酸を挙げることができる。
Examples of these basic components are water (solvent), BG, jojoba oil, squalane, glycerin (hydroxyethyl acrylate / acryloyldimethyltaurine Na) copolymer, pueraria myrfica root extract, hesperidin methyl chalcone, dipeptide-2, palmitoyl. Pentapeptide-3, palmitoyltetrapeptide-3, palmitoyl oligopeptide, chrysin, N-hydroxysuccinimide, acetyldipeptide-1cetyl, acetylhexapeptide-3, grapefruit extract, hyaluronic acid Na, tetrahexyldecanoate ascovir, cerebroside, Walthera indica leaf extract, betaine, PCA-Na, sorbitol, serine, glycine, glutamic acid, alanine, lysine, arginine, threonine, proline, evening primrose oil, white leaves Jellyfish polysaccharides, ferulic acid, sodium gluconate, hydrolyzed okra seed extract, tocopherol acetate, retinol palmitate, tocopherol linoleate, macadamia nut oil, dilauroyl glutamate (phytosteryl / octyldodecyl), dilauroyl glutamate (cholesteryl / octyldodecyl) , Diisostearyl malate, cyclopentasiloxane, dimethicone, 1,2-hexanediol, mannitol, dextrin, dimethiconol, citric acid, sodium citrate, caprylyl glycol, sorbitan oleate, polysorbate 80, steareth-20, laureth 3, hydroxyethyl cellulose, polysorbate 60,
塗布組成物Aは、例えば主要リンパ節(頚部リンパ節、鎖骨リンパ節等)に塗布される。 The coating composition A is applied to, for example, main lymph nodes (cervical lymph nodes, clavicular lymph nodes, etc.).
この発明により使用される塗布組成物Bは有効成分としてテトラヘキシルデカン酸アスコルビル、ワルテリアインディカ葉エキスを含むものである。 The coating composition B used according to the present invention contains ascorbyl tetrahexyl decanoate and Valteria indica leaf extract as active ingredients.
このうち、テトラヘキシルデカン酸アスコルビルは脂肪老廃物の生成原因である活性酸素を分解除去するものとして痩身効果を発揮する。 Among these, ascorbyl tetrahexyl decanoate exhibits a slimming effect as it decomposes and removes active oxygen which is the cause of the production of fat waste.
また、ワルテリアインディカ葉は南米フランス領ギアナで見つけられたヒメコバンノキ属の薬草であるが、そのエキスは美白作用の他に活性酸素除去作用があり、エキスはテトラヘキシルデカン酸アスコルビルの他に抗菌作用のあるフェルラ酸等と組み合わせて使用すると驚くべき痩身効果を発揮する。 In addition, Valteria indica leaf is a medicinal herb found in French Guiana in South America, but the extract has a reactive oxygen scavenging action in addition to a whitening action, and the extract has an antibacterial action in addition to ascorbyl tetrahexyldecanoate. When used in combination with ferulic acid or the like, it has a surprising slimming effect.
この他、塗布組成物Bには紅藻エキス、褐藻エキス、緑藻エキス等の海藻エキスが含まれ、またアラニン、リシン、アルギニン、トレオニン、プロリン、ベタイン、セリン、グリシン、グルタミン酸等のアミノ酸が含まれ、更にブエラリアミリフィカが含まれる。 In addition, the coating composition B includes seaweed extracts such as red algae extract, brown algae extract, and green algae extract, and also includes amino acids such as alanine, lysine, arginine, threonine, proline, betaine, serine, glycine, and glutamic acid. And Bueraria Mirifica.
このうち、紅藻エキス、褐藻エキス、緑藻エキス等の海藻エキスはリパーゼ活性作用を有し、皮脂を分解して痩身効果があり、またこのうち紅藻エキスは紅藻(オゴノリ、トサカノリ、テングサ、キリンサイ等)から抽出した海藻エキスで、水溶性高分子、ミネラルを豊富に含み、保湿力、抗酸化力に優れており、豊富なビタミンの働きで、他の海藻エキス(褐藻エキス、緑藻エキス)と組み合わせて使用することによりアンチエイジングの相乗効果が期待される。 Among these, seaweed extracts such as red algae extract, brown algae extract, green algae extract have lipase activity, and have a slimming effect by degrading sebum. Among these, red algae extract is red algae (Ogonori, Tosakanori, Tengusa, Seaweed extract extracted from giraffe, etc.) It contains abundant water-soluble polymers and minerals, has excellent moisturizing and antioxidant power, and other seaweed extracts (brown algae extract, green algae extract) by the action of abundant vitamins Anti-aging synergistic effect is expected by using in combination.
なお、褐藻エキスはもずく、わかめ、昆布などの褐藻類に特有のぬめりの成分として得られ糖類や高分子、水溶性ミネラルを含むエキスであり、その有効成分はフコイダンと言われるガラクトースやマンノースなどの糖が多数連結した高分子多糖類、食物繊維の一種であり、保湿作用に優れ、化粧品には血行促進作用のある成分としても配合される。 The brown algae extract is an extract containing saccharides, polymers, and water-soluble minerals that are obtained as a slime component unique to brown algae such as mozuku, seaweed, and kelp. Its active ingredients are galactose and mannose, which are called fucoidan. It is a kind of high-molecular polysaccharide and dietary fiber in which many sugars are linked, and has excellent moisturizing action and is also added to cosmetics as a component that promotes blood circulation.
更にこのうち緑藻エキスは褐藻や紅藻と同様な海藻エキスであるが、クロレラから抽出したものもある。 Furthermore, among these, the green algae extract is a seaweed extract similar to the brown algae and red algae, but there are some extracted from chlorella.
緑藻エキスには、海水由来のミネラルや各種ビタミンが豊富に含まれており、ミネラルは主にカルシウムやマグネシウムであるが、これらは皮膚の結合組織の接着に必要な成分であり、このため緑藻エキスには周囲の水分を引き寄せるので、皮膚の細胞を活性化させ、ハリのある肌を作るなど美白・保湿・ひきしめの作用がある。 Green algae extract is rich in minerals derived from seawater and various vitamins. Minerals are mainly calcium and magnesium, which are necessary for the adhesion of connective tissue of the skin. Since it attracts the surrounding water, it has the effect of whitening, moisturizing, and tightening by activating skin cells and creating firm skin.
一方、アラニンは糖質代謝に重要な関連を持つアミノ酸、リシンは体のタンパク質組立に不可欠なアミノ酸、アルギニンは体内でグルタミン酸から生成されるアミノ酸、トレオニンは食品から摂取する必要があるアミノ酸、プロリンはコラーゲンの主要要素であり、結合組織・心筋の合成時の主な材料となるアミノ酸、ベタインは不足分を体外から摂取する必要があるアミノ酸、セリンは体内で合成できるアミノ酸、グリシンは最も簡単な構造のアミノ酸、グルタミン酸は人体内に最も豊富に存在するアミノ酸であるが、これらアミノ酸は美肌、保湿などの化粧効果の他に、糖質などの新陳代謝機能、脂肪分解酵素を活性化させる機能を有し、これらの機能により痩身効果を挙げることができる。 On the other hand, alanine is an amino acid that is important for carbohydrate metabolism, lysine is an amino acid that is indispensable for protein assembly in the body, arginine is an amino acid that is produced from glutamic acid in the body, threonine is an amino acid that must be taken from food, and proline is Amino acid that is a major component of collagen and is the main material for the synthesis of connective tissue and myocardium, betaine is an amino acid that needs to be ingested from outside the body, serine is an amino acid that can be synthesized in the body, and glycine is the simplest structure Amino acid, glutamic acid, is the most abundant amino acid in the human body, but these amino acids have metabolic functions such as carbohydrates and functions that activate lipolytic enzymes in addition to cosmetic effects such as beautifying skin and moisturizing. These functions can give a slimming effect.
更に、プエラリアミリフィカはタイ北部の山岳民族が古くから不老長寿の植物・女性の若返り薬として愛用されているマメ科の植物であり、天然プエラリンや天然ミロエステロールなどの天然イソフラボン関連成分が多く含まれる。 Furthermore, Pueraria mirifica is a leguminous plant that has been used habitually by young hill tribes in northern Thailand as a rejuvenating agent for women who are not long-lived, and contains many natural isoflavone-related components such as natural puerarin and natural miroesterol. It is.
プエラリアミリフィカに含まれる天然イソフラボン関連成分は大豆イソフラボンの千倍〜一万倍の効果を発揮し、女性ホルモンのエストロゲン分泌を促進する作用がある。 Natural isoflavone-related components contained in Pueraria Mirifica are 1,000 to 10,000 times more effective than soybean isoflavones, and have the effect of promoting estrogen secretion of female hormones.
なお、この発明に用いる塗布組成物Bには、痩身効果乃至化粧料としても効果を発揮させるための基礎成分が配合される。 The coating composition B used in the present invention contains a basic component for exerting a slimming effect or a cosmetic effect.
これら基礎成分を例示すると、水(溶剤)、ブチレングリコール(BG)、加水分解オクラ種子エキス、甘草根エキス、ワイルドタイムエキス、グレープフルーツエキス、酢酸トコフェロール、トコフェロール、バルミチン酸レチノール、ヒアルロン酸Na、シラカンバ樹液、PCA-Na(DL-ピロリドンカルボン酸)、グルコシルヘスペリジン、カラスムギエキス、スクワラン、ピーナッツ油、マンニトール、ソルビトール、カブリリルグリコール、1,2−ヘキサンジオール、ラウリン酸ボリグリセリル-10、グリセリン、デキストリン、グルコン酸Na、クエン酸、クエン酸Na、水酸化カリウム、キサンタンガム、カルボマー、エチドロン酸、フェルラ酸を挙げることができる。 Examples of these basic components are water (solvent), butylene glycol (BG), hydrolyzed okra seed extract, licorice root extract, wild thyme extract, grapefruit extract, tocopherol acetate, tocopherol, retinol valmitate, sodium hyaluronate, birch sap , PCA-Na (DL-pyrrolidone carboxylic acid), glucosyl hesperidin, oat extract, squalane, peanut oil, mannitol, sorbitol, cabrilyl glycol, 1,2-hexanediol, polyglyceryl-10 laurate, glycerin, dextrin, glucone Examples include acid Na, citric acid, sodium citrate, potassium hydroxide, xanthan gum, carbomer, etidronic acid, and ferulic acid.
この発明に用いる塗布組成物Bは例えば腹回りに塗布される。 The coating composition B used in the present invention is applied, for example, around the stomach.
この発明に用いる生育光線は6〜14ミクロンの波長を有する遠赤外線であり、これらの生育光線は照射することにより体内の水分子と共鳴して水分子の活動が活性化され、微細血管の拡張、血液循環の促進、リンパの活性化、リパーゼの活性化、代謝の促進などが行われる。 The growth rays used in the present invention are far infrared rays having a wavelength of 6 to 14 microns, and when these growth rays are irradiated, the activity of the water molecules is activated by resonance with the water molecules in the body, and the expansion of the microvessels is performed. Promote blood circulation, activate lymph, activate lipase, promote metabolism, etc.
同時に、この発明においては生育光線の照射を55℃〜45℃、好ましくは50℃の雰囲気内で行われる。このような温度条件下で例えば約1時間生育光線の照射を行うことにより、体温は39℃程度になり、更に一層の微細血管の拡張、血液循環の促進、リンパの活性化、リパーゼの活性化、代謝の促進等がなされる。 At the same time, in this invention, the irradiation of the growth light is performed in an atmosphere of 55 ° C to 45 ° C, preferably 50 ° C. By irradiating the growth light for about 1 hour under such temperature conditions, the body temperature becomes about 39 ° C., and further expansion of microvessels, promotion of blood circulation, activation of lymph, activation of lipase Metabolism is promoted.
なお、体温が35℃台ではリンパの活性化の低下、リパーゼ活性化の低下、代謝の低下が見られる。 When the body temperature is in the range of 35 ° C., decreased lymph activation, decreased lipase activation, and decreased metabolism are observed.
したがって、この発明では塗布組成物A、Bを塗布して上記所定の温度で約1時間程度生育光線を照射するだけで痩身効果が得られるのである。 Therefore, in this invention, the slimming effect can be obtained only by applying the coating compositions A and B and irradiating the growing light at the predetermined temperature for about 1 hour.
なお、上述のような温度条件下での生育光線照射後、マッサージ手法によりリンパ液をリンパ節に誘導するようにすれば更なる痩身効果が得られる。 If the lymph is guided to the lymph node by a massage technique after irradiation with growth light under the temperature conditions as described above, a further slimming effect can be obtained.
一方、上述のような温度条件下での生育光線の照射処理は、放射性元素鉱物を含有させた床材の裏面側に温度調節機能を備えた加熱器を配設した保温マット(特開2006-75320)における放射性元素鉱物は遠赤外線(生育光線)を放出するので、マット内の温度を55℃〜45℃、好ましくは50℃近傍に設定して1時間程度マット内に入るようにしてもよい。 On the other hand, the irradiation treatment of the growing light under the temperature conditions as described above is performed by a heat retaining mat in which a heater having a temperature adjusting function is provided on the back side of the floor material containing a radioactive element mineral (Japanese Patent Laid-Open No. 2006-2006). 75320) emits far-infrared rays (growth rays), so the temperature inside the mat may be set to 55 ° C to 45 ° C, preferably around 50 ° C, so as to enter the mat for about 1 hour. .
以上要するに、この発明によればリンパ活性、リパーゼ活性を有する成分を含む特定の塗布組成物を塗布し、所定温度で所定時間生育光線を照射するだけで顕著な痩身効果を発揮させることができる。 In short, according to the present invention, it is possible to exert a remarkable slimming effect simply by applying a specific coating composition containing a component having lymph activity and lipase activity and irradiating a growing beam for a predetermined time at a predetermined temperature.
エトキシヘプチルビシクロオクタノンとワイルドタイムエキスと甘草フラボノイドの有効成分を含む塗布組成物Aとテトラヘキシルデカン酸アスコルビル、ワルテリアインディカ葉エキスを含む塗布組成物Bを塗布した後、55℃〜45℃、好ましくは50℃で1時間程度保持しながら生育光線を照射する痩身方法 After applying coating composition A containing ethoxyheptylbicyclooctanone, wild thyme extract and active ingredients of licorice flavonoid and coating composition B containing tetrahexyl decanoate ascorbyl and walteria indica leaf extract, 55 ° C to 45 ° C, preferably Is a slimming method that irradiates growth light while holding at 50 ° C for about 1 hour
つぎに、この発明に係る痩身方法を実施例を挙げて説明する。
(1)塗布組成物A
(a)基礎成分
水(溶剤)、BG、ホホバ油、スクワラン、グリセリン(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、プエラリアミルフィカ根エキス、ヘスペリジンメチルカルコン、ジペプチド−2、パルミトイルペンタペプチド−3、パルミトイルテトラペプチド−3、パルミトイルオリゴペプチド、クリシン、N−ヒドロキシコハク酸イミド、アセチルペプチド−1セチル、アセチルヘキサペプチド−3、グレープフルーツエキス、ヒアルロン酸Na、テトラヘキシルデカン酸アスコビル、セレブロシド、ワルテリアインディカ葉エキス、ベタイン、PCA-Na、ソルビトール、セリン、グリシン、グルタミン酸、アラニン、リシン、アルギニン、トレオニン、プロリン、月見草油、シロキクラゲ多糖体、フェルラ酸、グルコン酸Na、加水分解オクラ種子エキス、酢酸トコフェロール、パルミチン酸レチノール、リノール酸トコフェロール、マカデミアナッツ油、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル)、リンゴ酸ジイソステアリル、シクロペンタシロキサン、ジメチコン、1,2−ヘキサンジオール、マンニトール、デキストリン、ジメチコノール、クエン酸、クエン酸Na、カプリリルグリコール、オレイン酸ソルビタン、ポリソルベート80、ステアレス−20、ラウレス−3、ヒドロキシエチルセルロース、ポリソルベート60、ポリソルベート20、カルボマ−、ラウリン酸ポリグリセリル−10、ピーナッツ油、ペンチレングリコール、エチドロン酸
(b)エトキシヘプチルビシクロオクタノン
(c)ワイルドタイムエキス
(d)甘草フラボノイド
Next, the slimming method according to the present invention will be described with reference to examples.
(1) Coating composition A
(a) Basic components Water (solvent), BG, jojoba oil, squalane, glycerin (hydroxyethyl acrylate / acryloyldimethyltaurine Na) copolymer, Pueraria myrfica root extract, hesperidin methyl chalcone, dipeptide-2, palmitoylpentapeptide-3 , Palmitoyl tetrapeptide-3, palmitoyl oligopeptide, chrysin, N-hydroxysuccinimide, acetyl peptide-1 cetyl, acetyl hexapeptide-3, grapefruit extract, hyaluronic acid Na, ascovir tetrahexyldecanoate, cerebroside, walteria indica leaf Extract, betaine, PCA-Na, sorbitol, serine, glycine, glutamic acid, alanine, lysine, arginine, threonine, proline, evening primrose oil, white jellyfish polysaccharide, ferula , Sodium gluconate, hydrolyzed okra seed extract, tocopherol acetate, retinol palmitate, tocopherol linoleate, macadamia nut oil, dilauroyl glutamate (phytosteryl / octyldodecyl), dilauroyl glutamate (cholesteryl / octyldodecyl), diisostearyl malate , Cyclopentasiloxane, dimethicone, 1,2-hexanediol, mannitol, dextrin, dimethiconol, citric acid, sodium citrate, caprylyl glycol, sorbitan oleate, polysorbate 80, steareth-20, laureth-3, hydroxyethyl cellulose, polysorbate 60,
(2)塗布組成物Aの成分配合割合
(a)基礎成分 98重量%
(b)エトキシヘプチルビシクロオクタノン 0.3重量%
(c)ワイルドタイムエキス 1.0重量%
(d)甘草フラボノイド 0.7重量%
(2) Composition ratio of coating composition A (a) 98% by weight of basic component
(B) Ethoxyheptylbicyclooctanone 0.3% by weight
(C) Wild time extract 1.0 wt%
(D) Licorice flavonoid 0.7% by weight
(3)塗布組成物B
(a)基礎成分
水(溶剤)、ブチレングリコール(BG)、加水分解オクラ種子エキス、甘草根エキス、ワイルドタイムエキス、グレープフルーツエキス、酢酸トコフェロール、トコフェロール、パルミチン酸レチノール、ヒアルロン酸Na、シラカンバ樹液、PCA-Na(DL-ピロリドンカルボン酸)、グルコシルヘスベリジン、カラスムギエキス、スクワラン、ピーナッツ油、マンニトール、ソルビトール、カブリリルグルコール、1,2−ヘキサンジオール、ラウリン酸ポリグリセリル-10、グリセリン、デキストリン、グルコン酸Na、クエン酸、クエン酸Na、水酸化カリウム、キサンタンガム、カルボマー、エチドロン酸、フェルラ酸
(b)テトラヘキシルデカン酸アスコルビル、ワルテリアインディカ葉エキスからなる活性酸素除去剤
(c)アラニン、リシン、アルギニン、トレオニン、プロリン、ベタイン、セリン、グリシン、グルタミン酸からなるアミノ酸
(d)ブエラリアミリフィカ
(3) Coating composition B
(A) Basic components Water (solvent), butylene glycol (BG), hydrolyzed okra seed extract, licorice root extract, wild thyme extract, grapefruit extract, tocopherol acetate, tocopherol, retinol palmitate, sodium hyaluronate, birch sap, PCA -Na (DL-pyrrolidone carboxylic acid), glucosyl hesperidin, oat extract, squalane, peanut oil, mannitol, sorbitol, cabryl glycol, 1,2-hexanediol, polyglyceryl-10 laurate, glycerin, dextrin, glucone Acid Na, Citric acid, Na citrate, Potassium hydroxide, Xanthan gum, Carbomer, Etidronic acid, Ferulic acid (b) Reactive oxygen scavenger consisting of ascorbyl tetrahexyl decanoate, Valteria indica leaf extract (c) A Nin, lysine, arginine, threonine, proline, betaine, serine, glycine, an amino acid (d) blanking gills rear Mirifica consisting of glutamic acid
(4)塗布組成物Bの成分配合割合
(a)基礎成分 94重量%
(b)活性酸素除去剤 3重量%
(テトラヘキシルデカン酸アスコルビル2重量%、ワルテリアインディカ葉エキス1重量%)
(c)アミノ酸 2重量%
(d)ブエラリアミリフィカ 1重量%
(4) Component composition ratio of coating composition B (a) 94% by weight of basic component
(B) Active oxygen scavenger 3% by weight
(Ascorbyl tetrahexyl decanoate 2% by weight, Valteria indica leaf extract 1% by weight)
(C) 2% by weight of amino acid
(D) Bueraria Mirifica 1% by weight
(5)施術例
塗布組成物Aを主要リンパ節に塗布し、塗布組成物Bを腹回りに塗布した後、放射性元素鉱物を含有させた床材の裏面側に温度調節機能を備えた加熱器を配設した保温マット内の温度を50℃近傍に設定して1時間程度マット内に入る。
(5) Example of treatment After applying the coating composition A to the main lymph nodes and coating the coating composition B around the abdomen, a heater having a temperature control function on the back surface side of the flooring containing the radioactive element mineral Set the temperature in the heat retaining mat with the temperature around 50 ° C. and enter the mat for about 1 hour.
(6)施術結果
やせ型、普通、肥満体型の30代〜70代の被施術者50件に対して上述の施術を施し、へそ上5cm、へそ位置、へそ下5cmの3箇所について施術前と施術後とその差及びそれらの合計値を下記表1に示す。
(6) Surgical results The above-mentioned treatment is applied to 50 patients in their 30s to 70s who are thin, normal, and obese, and before the treatment with respect to three places of the
実施例1の施術後、マッサージ手法によりリンパ液をリンパ節に誘導するようなマッサージ処理を行った。 After the treatment in Example 1, massage treatment was performed to induce lymph to the lymph nodes by a massage technique.
施術結果
やせ型、普通、肥満体型の30代〜70代の被施術者50件に対して上述の施術を施し、へそ上5cm、へそ位置、へそ下5cmの3箇所について施術前と施術後とその差及びそれらの合計値を下記表2に示す。
Results of treatment The above-mentioned treatment is applied to 50 skinny, normal, and obese patients in their 30s to 70s, and before and after treatment for 3 places, 5 cm above the navel, 5 cm below the navel, and 5 cm below the navel. The differences and their total values are shown in Table 2 below.
この発明によればリンパ活性、リパーゼ活性を有する成分を含む特定の塗布組成物を塗布した後、所定温度で所定時間生育光線を照射することにより顕著な痩身効果を発揮させることができる。 According to this invention, after applying a specific coating composition containing a component having lymph activity and lipase activity, a remarkable slimming effect can be exerted by irradiating a growing light for a predetermined time at a predetermined temperature.
Claims (2)
水、BG(ブチレングリコール)、加水分解オクラ種子エキス、甘草根エキス、ワイルドタイムエキス、グレープフルーツエキス、酢酸トコフェロール、トコフェロール、パルミチン酸レチノール、ヒアルロン酸Na、シラカンバ樹液、PCA-Na(DL−ピロリドンカルボン酸)、グルコシルヘスペリジン、カラスムギエキス、スクワラン、ピーナッツ油、マンニトール、ソルビトール、カプリリルグルコール、1.2−ヘキサンジオール、ラウリン酸ポリグリセリル−10、グリセリン、デキストリン、グルコン酸Na、クエン酸、クエン酸Na、水酸化カリウム、キサンタンガム、カルボマー、エチドロン酸、フェルラ酸を基礎成分とし、テトラヘキシルデカン酸アスコルビル、ワルテリアインディカ葉エキスからなる活性酸素除去剤、アラニン、リシン、アルギニン、トレオニン、プロリン、ベタイン、セリン、グリシン、グルタミン酸からなるアミノ酸、紅藻エキス、褐藻エキス、緑藻エキス、プエラリアミリフィカからなる痩身目的部位に塗布する塗布組成物Bからなる痩身用塗布剤。 Water, BG (butylene glycol), hydrolyzed okra seed extract, licorice root extract, wild thyme extract, grapefruit extract, tocopherol acetate, tocopherol, retinol palmitate, sodium hyaluronate, birch sap, PCA-Na (DL-pyrrolidone carboxylic acid) ), Glucosyl hesperidin, oat extract, squalane, peanut oil, mannitol, sorbitol, caprylyl glycol, 1.2-hexanediol, polyglyceryl-10 laurate, glycerin, dextrin, sodium gluconate, citric acid, sodium citrate, Reactive oxygen scavenger consisting of potassium hydroxide, xanthan gum, carbomer, etidronic acid, ferulic acid, ascorbyl tetrahexyl decanoate, and Valteria indica leaf extract, alanine, Emissions, arginine, threonine, proline, betaine, serine, glycine, consisting glutamic acid, red algae extract, brown algae extract, green algae extract, slimming coating agent consisting coating composition B applied to the slimming target site consisting of Pueraria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009143803A JP4993391B2 (en) | 2009-06-17 | 2009-06-17 | Slimming application agent for slimming method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009143803A JP4993391B2 (en) | 2009-06-17 | 2009-06-17 | Slimming application agent for slimming method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011001276A JP2011001276A (en) | 2011-01-06 |
JP4993391B2 true JP4993391B2 (en) | 2012-08-08 |
Family
ID=43559560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009143803A Expired - Fee Related JP4993391B2 (en) | 2009-06-17 | 2009-06-17 | Slimming application agent for slimming method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4993391B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013107862A (en) * | 2011-11-24 | 2013-06-06 | Dhc Co | Skin cosmetic gel |
JP5766674B2 (en) * | 2012-09-27 | 2015-08-19 | 敏 新川 | Slimming equipment and slimming application agent for lymphoid slimming |
WO2014065303A1 (en) * | 2012-10-23 | 2014-05-01 | ロート製薬株式会社 | External composition for skin |
JP6859017B2 (en) * | 2014-10-31 | 2021-04-14 | 第一産業株式会社 | Topical cream and its manufacturing method |
US20220401761A1 (en) * | 2019-10-30 | 2022-12-22 | Toyo Sugar Refining Co., Ltd. | Skin External Preparation for Cellulite Improvement and Cellulite Improvement Method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764190B1 (en) * | 1997-06-06 | 1999-10-15 | Serobiologiques Lab Sa | COSMETIC PRODUCT COMPRISING PLANT EXTRACTS, PARTICULARLY WITH DEPIGMENTING, ANTI-RADICAL AND ANTI-AGING ACTION |
AU2001271031A1 (en) * | 2000-07-13 | 2002-01-30 | Kawai Cosmetic Co., Ltd | Cosmetic compositions for reducing and method of using the same |
JP4618711B2 (en) * | 2004-09-07 | 2011-01-26 | 株式会社シマノ | Telescopic fishing rod |
-
2009
- 2009-06-17 JP JP2009143803A patent/JP4993391B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2011001276A (en) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101584742B1 (en) | Cosmetic composition for improving skin-aging | |
EP1813309A1 (en) | Abnormal protein removing composition | |
CN111166683A (en) | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof | |
JP2010132629A (en) | External composition for skin | |
CN103211730B (en) | Beauty essence made from natural Chinese herbal medicine, and preparation method thereof | |
JP4993391B2 (en) | Slimming application agent for slimming method | |
WO2017148180A1 (en) | Rosemary moisturizing solution and manufacturing method therefor | |
JP2003160505A (en) | Food and drink as well as external preparation with body fat reducing effect | |
KR20200063855A (en) | A composition for promoting melanin synthesis comprising flower extract of milk thistle | |
CN105919913B (en) | A kind of skin care compositions and paste prepared therefrom compact frost | |
CN110585083A (en) | Preparation method of okra-based extract and application of okra-based extract as cosmetic matrix | |
CN104971015A (en) | Facial mask product special for oily skin and preparation method thereof | |
JP2002212087A (en) | Skin care preparation | |
JP3991164B2 (en) | Cosmetic composition comprising jujube extract and walnut extract | |
JP4136203B2 (en) | Skin preparation for external use | |
JP3791775B2 (en) | Topical skin preparation | |
JP6263346B2 (en) | Skin preparations and cosmetics | |
CN108553365A (en) | A kind of apple myofilament sliding surface film and preparation method thereof | |
CN102949328B (en) | Toning lotion with functions of anti-senile, wrinkle-dispelling and moisturizing and preparation method thereof | |
CN104398426A (en) | Mask for treating common acne | |
JP5863225B2 (en) | Skin care composition | |
JP2007063207A (en) | Adiponectin production promoter | |
JP4638963B2 (en) | Slimming cosmetic composition | |
KR102157210B1 (en) | The functional cosmetic composition comprising extract of natural micro organism-fermented black ginseng | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120217 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120405 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120425 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120427 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150518 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4993391 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |